Cargando…
Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
Metastatic triple-negative breast cancer (TNBC) is a heterogeneous disease with a poor prognosis and currently with few treatment options. Treatment of these patients is highly based on systemic chemotherapy. Some targeted drugs were recently approved for these patients: two poly(ADP-ribose) polymer...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989121/ https://www.ncbi.nlm.nih.gov/pubmed/33814914 http://dx.doi.org/10.1177/11782234211002491 |